Related Experiment Videos
[Therapy of multiple sclerosis with interferon-beta-1b. Educating the patient and managing side-effects]
E U Walther1, E Dietrich, R Hohlfeld
1Neurologische Klinik und Poliklinik, Klinikum Grosshadern, München.
Der Nervenarzt
|June 1, 1996
Abstract:
Interferon beta-1b has been shown to reduce the frequency and severity of exacerbations in relapsing-remitting multiple sclerosis (MS). Unrealistic expectations of the patient and unexpected side effects may lead to discontinuation of the drug. Here we provide guidelines how to inform the patient adequately before therapy and discuss the most common side effects of interferon therapy.